Tata Capital Healthcare Fund
VC Fund
Mumbai, India
Tata Capital Healthcare Fund is a VC fund in Mumbai focused on Health Care and Pharmaceutical. The Tata Capital Healthcare Fund is a growth-oriented private equity fund focused on the healthcare and life sciences sector in India.
- Total investments:
- 18
- Last investment:
- Lead investor:
- 28%
Last updated:
For AI agents: llms.txt
Industries Tata Capital Healthcare Fund invests in
Stages Tata Capital Healthcare Fund invests in
Countries Tata Capital Healthcare Fund invests in
Investment Focus
Industry
- Health Care 12 (67%)
- Pharmaceutical 9 (50%)
- Manufacturing 7 (39%)
- Medical 4 (22%)
- Hospital 4 (22%)
Stage
- Private Equity 12 (67%)
- Series A 3 (17%)
- Funding Round 2 (11%)
- Post-IPO Equity 1 (6%)
Country
- India 16 (89%)
- United States 2 (11%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Harsoria Healthcare
|
Harsoria Healthcare is a manufacturing company. Harsoria has installed its design and development section, the medical devices production sections, and the quality control and assurance section. their products range from iv cannula, three way stop cock, av fistula needle, extension tube, flow regulator, connectors, stoppers, infusion set, centralvenous catheter, transfusion set, safety iv cannula, and hemodialysis catheter. | $20M / Private Equity / Jan 09, 2025 | |
Orbicular Pharmaceutical Technologies
|
Orbicular Pharmaceutical Technologies develops niche and complex pharmaceutical dosage forms for licensing to its global partners. | $20M / Private Equity / May 31, 2024 | |
Noble Plus
|
Noble Plus is a pharmacy that sells dermocosmetics, nutraceuticals, grooming, ayurveda, body, and hair care products. | Private Equity / Apr 01, 2024 | |
Apex Kidney Care
|
Apex Kidney Care offers medical services and kidney care services to patients suffering from kidney disease. They are services that can help you maintain your current lifestyle. They provide dialysis and help patients lead a more fulfilling life at the same time. An online inquiry form is available on the company's website. | $10M / Private Equity / Oct 11, 2023 | |
|
Sakar Healthcare
|
Sakar Healthcare is a producer of pharmaceutical products. They provide products that include tablets, capsules, dry powder syrup, dry powder injections, liquid injectable ampoules, and vials of lyophilized injections. | Post-IPO Equity / Aug 04, 2023 | |
Mumbai Oncocare Center
|
Mumbai Oncocare Center provides oncology and hematology healthcare services with qualified doctors in cancer treatment and related services in a state-of-the Art facility coupled with seamless healthcare services for patients. | $10.1M / Series A / Jan 14, 2023 | |
Anderson Diagnostics & Labs
|
Anderson Diagnostics & Labs specializes in prenatal genetic and newborn screening, neurogenetics, mammography and PET-CT scan services. | Private Equity / Jun 01, 2022 | |
DeepTek
|
AI is a technology for the people. AI has the power and potential to radically transform healthcare. Deeptek will use in-house innovated "assisted and augmented" (AaA) imaging focused algorithmic tools designed by our experts and covering a wide arena of medical imaging like Radiographs, CT Scan and MRI. Deeptek's aim is to savehundreds of hours of valuable time of caregivers of the society, in our case radiologists! Saved time means additional reach of caregivers in treating more individuals in need of care and giving prompt results in time. Saved time on workflow management amounts to drastic saving in cost of healthcare by appropriate use of valuable time of experts like radiologists. DeepTek's vision will be to provide cutting edge solutions powered by deep learning algorithms which will bridge the wide gap in the imaging sector empowering radiologists with power which can potentially disrupt the dynamics of radiology workflow. Deeptek uses the latest technology to POWER ON the grid of medical radiology imaging. Be it the cloud powered GPU offerings which trigger the artificial neural networks, deep neural nets customized to the task at hand to advanced API, seamless interfaces and simple to use GUI, the radiologists will have it all on a platter. Deeptek's offerings will change your workstations and mobile devices to dependable analytical tools, which gives radiologists the confidence, reach and benefits of AI tech so that you could do more in less time. | $10M / Series A / Mar 07, 2022 | |
Atulaya Healthcare
|
Atulaya Healthcare provides covid-19, radiology, and pathology treatments. | Private Equity / Aug 01, 2021 | |
Linux Laboratories
|
Linux Laboratories Private Limited is a pharmaceutical company that focuses on manufacturing and marketing a range of medicinal products. The company operates from Chennai, India, and provides essential medicines to a large number of patients. Linux Laboratories is known for its domestic formulations and has a significant presence in thepharmaceutical industry. The company's operations extend to various therapeutic areas, and it is committed to improving the health and well-being of people through its products. | Private Equity / Feb 01, 2021 | |
| See all 18 investments → | |||
Co-Investors
Tata Capital
5 deals together
GHV Accelerator
1 deal together
LNB group
1 deal together
Pentathlon Ventures
1 deal together
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Featured in Investor Lists
Recommended lists
FAQ
What does Tata Capital Healthcare Fund invest in?
Tata Capital Healthcare Fund invests primarily in Health Care, Pharmaceutical and Manufacturing startups, most often at Private Equity and Series A stage. Most of the 18 investments tracked by Shizune back companies in India. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Tata Capital Healthcare Fund last invest?
The most recent investment recorded for Tata Capital Healthcare Fund closed in Jan 2025. Shizune tracks 18 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
